PGD2 LC-MS/MS Quantification Without Derivatization
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need for analytical techniques that can accurately measure prostaglandins, such as PGD2, for clinical diagnosis and research due to their role in various physiological and pathological processes.
Innovation Solution
A method and system utilizing liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) for the detection and quantification of prostaglandins, particularly PGD2, without the need for derivatization, involving steps like sample preparation, chromatographic separation, and mass spectrometric analysis, including the use of stable isotope-labeled internal standards and high turbulence liquid chromatography (HTLC).
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional analytical methods are used to measure prostaglandins, then the measurement process becomes complex and time-consuming, but the sensitivity and specificity required for clinical diagnosis cannot be achieved
Solution Approach 1:
The analytical method is segmented into distinct operational phases: sample preparation with internal standards, chromatographic separation, and mass spectrometric detection. This segmentation allows each phase to be optimized independently, achieving high precision through targeted procedures while managing overall complexity through systematic organization of steps.
Solution Approach 2:
The method utilizes parameter changes in the mass spectrometer (mass-to-charge ratio detection) and chromatography conditions to achieve specific detection of prostaglandins. By monitoring specific m/z transitions and optimizing chromatographic parameters, the method achieves clinical-grade sensitivity and specificity without requiring overly complex procedural interventions.
2Measurement precision
If derivatization processes are used to enhance detection, then sensitivity improves, but the procedure time and complexity increase significantly
Solution Approach 1:
The method extracts and detects prostaglandins in their native form using stable isotope-labeled internal standards and direct LC-MS/MS analysis. By taking out the derivatization step entirely and relying on the inherent detectability of prostaglandins through mass spectrometry, the method achieves high sensitivity while eliminating the time-consuming derivatization procedures that traditionally preceded detection.
Solution Approach 2:
Stable isotope-labeled prostaglandin internal standards serve as intermediaries that facilitate direct detection without derivatization. These labeled standards co-elute with native prostaglandins and provide internal reference points for quantification, enabling sensitive detection through mass spectrometric ratio measurements while avoiding additional chemical modification steps.
3Measurement precision
If extensive sample preparation is performed to purify prostaglandins, then measurement accuracy improves, but productivity and throughput decrease
Solution Approach 1:
Stable isotope-labeled internal standards are added to samples during preliminary preparation steps before chromatographic separation. This preliminary action ensures that the internal standards are present throughout the entire analytical process, allowing for accurate quantification correction of matrix effects and variations without requiring extensive post-separation purification procedures, thus maintaining high throughput.
Solution Approach 2:
The LC-MS/MS method serves multiple functions simultaneously: it separates prostaglandins from matrix components, detects them with high sensitivity through mass spectrometry, and quantifies them using internal standard ratios. This multi-functionality eliminates the need for separate, time-consuming purification and analysis steps, thereby maintaining high productivity while achieving accurate quantification.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method provides accurate, sensitive, and specific detection of PGD2 at low levels, enabling clinical applications and rapid throughput, with improved sensitivity and specificity over existing methods, suitable for complex biological samples.
Implementation Method 1
chromatographically separating the at least one biomarker of interest from other components in the sample
Implementation Method 2
analyzing the chromatographically separated at least one biomarker of interest by mass spectrometry to determine the presence or amount of the at least one biomarker of interest in the sample
Implementation Method 3
generating a precursor ion of the PGD2; generating one or more fragment ions of the precursor ion; detecting the presence or amount of the precursor ion generated in step (i) and/or the at least one or more fragment ions generated in step (ii)
Data Source
AI summary
Disclosed are methods, systems, and computer program products for using liquid chromatography/tandem mass spectrometry (LC-MS/MS) for the analysis of endogenous biomarkers, such as PGD2, in a biological sample. More specifically, the methods, systems, and computer program products are described for detecting and quantifying the amount of an PGD2 in a sample. The quantitative analysis may be helpful in making clinical diagnoses.